Libenzapril
Product Specifications
UNSPSC Description
Libenzapril (Abutapril; CGS-16617) is an orally active, potent direct-acting angiotensin-converting-enzyme (ACE) inhibitor. Libenzapril has the potential for ischemia-induced heart failure research[1].
Target Antigen
Angiotensin-converting Enzyme (ACE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/libenzapril.html
Smiles
O=C1N(C2=CC=CC=C2CC[C@@H]1N[C@H](C(O)=O)CCCCN)CC(O)=O
Molecular Weight
363.41
References & Citations
[1]E F Smith 3rd, et al. Effects of two nonsulfhydryl angiotensin-converting enzyme inhibitors, CGS 14831 and CGS 16617, on myocardial damage and left-ventricular hypertrophy following coronary artery occlusion in the rat. Pharmacology. 1988;37(4):254-63.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-50761/Libenzapril-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-50761/
Clinical Information
No Development Reported
CAS Number
109214-55-3
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC227473L4V 200 µL
Leukotriene B4 Receptor (LTB4R) (NM_001143919) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details 